Patrick Buckley

Patrick Buckley is a Senior Validation Specialist at CSL Seqirus since June 2014, focusing on the stability and quality analysis of influenza vaccine products through various laboratory techniques. Prior experience includes roles as a Laboratory Scientist and Immunoassay Scientist at ICON plc, where analysis of clinical samples was conducted in compliance with GLP and GCP guidelines. Additional experience encompasses being a GMP Scientist at Angel Biotechnology, a Senior Research Scientist at Antibody Applications, and a Bioscientist at AstraZeneca. Patrick Buckley began an academic career as a Research Associate at the University of Manchester, and holds a PhD in Protein Crystallography from The University of Sheffield, an MSc in Biotechnology from Teesside University, and a BSc in Biophysics from Liverpool John Moores University.